Efficacy News and Research

RSS
ARIAD to complete its Phase 3 SUCCEED trial following DMS recommendation

ARIAD to complete its Phase 3 SUCCEED trial following DMS recommendation

ALF, Celsion partner to educate physicians about primary liver cancer treatments

ALF, Celsion partner to educate physicians about primary liver cancer treatments

Final results of SAPHRIS clinical study released

Final results of SAPHRIS clinical study released

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed

Chinese SFDA approves Abbott's XIENCE V drug eluting stent for treating coronary artery disease

Chinese SFDA approves Abbott's XIENCE V drug eluting stent for treating coronary artery disease

VBI's flu vaccine offers protection against H1N1

VBI's flu vaccine offers protection against H1N1

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Schizophrenia: A major public health problem

Schizophrenia: A major public health problem

Phase IIa clinical data of EHT 0202 released

Phase IIa clinical data of EHT 0202 released

Phase III STARTMRK clinical study on ISENTRESS in comparison to efavirenz

Phase III STARTMRK clinical study on ISENTRESS in comparison to efavirenz

U.S. Department of Justice awards grant to Project Lifesaver International

U.S. Department of Justice awards grant to Project Lifesaver International

Clinical data emphasizing on efficacy and potency of torezolid to be presented

Clinical data emphasizing on efficacy and potency of torezolid to be presented

Trabedersen granted orphan drug designation from both FDA And EMEA for treating pancreatic carcinoma

Trabedersen granted orphan drug designation from both FDA And EMEA for treating pancreatic carcinoma

Data from Phase III clinical trial of TYSABRI presented at ECTRIMS

Data from Phase III clinical trial of TYSABRI presented at ECTRIMS

FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections

Laquinimod study data reveals its neuroprotective and anti-inflammatory properties

Laquinimod study data reveals its neuroprotective and anti-inflammatory properties

Phase IIa trial results of panobacumab released

Phase IIa trial results of panobacumab released

Naproxcinod clinical study results presented at the 2009 World Congress on Osteoarthritis

Naproxcinod clinical study results presented at the 2009 World Congress on Osteoarthritis

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept

FAB Pharma to develop new class of anti-MRSA drugs

FAB Pharma to develop new class of anti-MRSA drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.